Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible

NCT05937958 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05937958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05937958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2023
Completion date
October 1, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, gynecologic cancer